Celsense Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Celsense Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10822
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Celsense Inc (Celsense) is a biotechnology company that develops magnetic resonance imaging detection products to monitor the location and quantity of transplanted cells. The company’s products include v-sense, cell sense and voxel tracker. Its v-sense product is a reagent used to detect various lesions and diseases such as cancer, cardiovascular disease, autoimmune disease, infectious pathogens, and injury. Celsense offers developing cell labeling protocols, validation studies, imaging experimental design, and study management services. The company’s products are used for inflammation and transplanted cells for therapeutic and diagnostic applications. Celsense is headquartered in Pittsburgh, Pennsylvania, the US.

Celsense Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Celsense Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Celsense Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Celsense Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Celsense Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Celsense Inc, Medical Devices Deals, 2012 to YTD 2018 9
Celsense Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Celsense Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Celsense Raises USD0.1 Million in Venture Financing 11
Celsense Raises USD0.1 Million in Venture Financing 12
Celsense Raises Additional USD0.4 Million in Venture Financing 13
Celsense Raises USD0.24 Million in Venture Financing 14
Celsense Raises USD0.3 Million in Venture Financing 15
Celsense Raises US$0.13 Million In Venture Financing 16
Celsense Inc – Key Competitors 17
Celsense Inc – Key Employees 18
Celsense Inc – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Celsense Inc, Pharmaceuticals & Healthcare, Key Facts 2
Celsense Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Celsense Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Celsense Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Celsense Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Celsense Inc, Medical Devices Deals, 2012 to YTD 2018 9
Celsense Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Celsense Raises USD0.1 Million in Venture Financing 11
Celsense Raises USD0.1 Million in Venture Financing 12
Celsense Raises Additional USD0.4 Million in Venture Financing 13
Celsense Raises USD0.24 Million in Venture Financing 14
Celsense Raises USD0.3 Million in Venture Financing 15
Celsense Raises US$0.13 Million In Venture Financing 16
Celsense Inc, Key Competitors 17
Celsense Inc, Key Employees 18

List of Figures
Celsense Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Celsense Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Celsense Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Celsense Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Celsense Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Celsense Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Celsense Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Celsense Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Celsense Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AEI Services LLC-エネルギー分野:企業M&A・提携分析
    Summary AEI Services LLC (AEI), formerly Ashmore Energy International, is an energy utility company that owns, develops and operates power generation assets. The company also carries out the natural gas transportation and distribution businesses in emerging markets. Its power generation portfolio co …
  • Technopromexport:企業の戦略的SWOT分析
    Technopromexport - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Public Establishment for Electricity Generation and Transmission Co:企業の戦略的SWOT分析
    Public Establishment for Electricity Generation and Transmission Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key empl …
  • X4 Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary X4 Pharmaceuticals Inc (X4 Pharma) is a clinical stage biotechnology company that develops novel therapeutics to treat cancer and rare diseases. The company’s lead drug candidate, X4P-001-LD, is in Phase 2/3 trial used for the treatment for patients with WHIM and other immunodeficiencies. It …
  • Avantec Vascular Corp:企業の製品パイプライン分析2018
    Summary Avantec Vascular Corp (Avantec Vascular), a subsidiary of Goodman Co Ltd, is a medical device company that develops cardiovascular interventional and peripheral vascular devices. The company's products comprise balloon catheter, aspiration catheter, device delivery system, micro catheter, gu …
  • Shandong Airlines Co., Ltd.:企業の戦略・SWOT・財務分析
    Shandong Airlines Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shandong Airlines Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Alfresa Holdings Corp (2784):企業の財務・戦略的SWOT分析
    Summary Alfresa Holdings Corp (Alfresa) is a wholesale distributor and manufacturer of pharmaceuticals products. The company is engaged in ethical pharmaceuticals wholesaling business which delivers a wide range of products, including diagnostic reagents and medical devices. It delivers self medicat …
  • Red River Valley Mutual Insurance Company:企業の戦略・SWOT・財務情報
    Red River Valley Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Red River Valley Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • The Hospital for Sick Children-製薬・医療分野:企業M&A・提携分析
    Summary The Hospital for Sick Children (SickKids) is a healthcare service provider that offers children care services. The hospital offers programs and services including resources, tele-medicine, accommodations, child life, creative arts therapy, child and family-centered care; health records inqui …
  • Nammo AS:企業の戦略・SWOT・財務情報
    Nammo AS - Strategy, SWOT and Corporate Finance Report Summary Nammo AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Endotronix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Endotronix Inc (Endotronix) is a medical technology company that offers digital health solutions. The company offers Cordella Heart Failure System with an implantable wireless pulmonary artery sensor for early detection of worsening heart failure. Endotronix’s solution includes an implanted …
  • Moldex-Metric Inc:企業の戦略的SWOT分析
    Moldex-Metric Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Vietnam National Oil and Gas Group:石油・ガス:M&Aディール及び事業提携情報
    Summary Vietnam National Oil and Gas Group (Petrovietnam) is an oil and gas exploration and production company. The company conducts petroleum activities and signs petroleum contracts with organizations and individuals. Its services include oil and natural gas exploration and production, petroleum a …
  • Bioneer Corp (064550):医療機器:M&Aディール及び事業提携情報
    Summary Bioneer Corp (Bioneer) is a molecular diagnostic company that develops and produces molecular research and molecular diagnostic products and instruments. The company’s major molecular research products include DNA/RNA amplification pre mixes, DNA/RNA preparation system, oligo synthesis and r …
  • Penske Automotive Group, Inc.:企業の戦略・SWOT・財務情報
    Penske Automotive Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Penske Automotive Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • America Movil, SA DE C.V.:戦略・SWOT・企業財務分析
    America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report Summary America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Eidgenossische Technische Hochschule Zurich-製薬・医療分野:企業M&A・提携分析
    Summary Eidgenossische Technische Hochschule Zurich(ETH Zurich) is an educational university that offers studies in technology and the natural sciences. The university provides scientific education through bachelor programmes and master programmes in the areas of applied geophysics, architecture, bi …
  • Baxter International Inc (BAX):医療機器:M&Aディール及び事業提携情報
    Summary Baxter International Inc (Baxter) is a provider of healthcare products, including dialysis in acute and chronic conditions, sterile intravenous solutions, parenteral nutrition therapies, generic injectable pharmaceuticals, infusion systems and devices, inhaled anesthetics, and surgical hemos …
  • Bouwinvest Real Estate Investment Management B.V.:企業の戦略・SWOT・財務情報
    Bouwinvest Real Estate Investment Management B.V. - Strategy, SWOT and Corporate Finance Report Summary Bouwinvest Real Estate Investment Management B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • Electricidade de Mocambique EP:企業の戦略的SWOT分析
    Electricidade de Mocambique EP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆